Story perspectives

Nicotinamide Cuts Skin Cancer Risk by 14%, Study Finds

9/18/2025

44 6

Summary

Story summary

A Vanderbilt University Medical Center study indicates that nicotinamide, a vitamin B3 derivative, may lower skin cancer risk by 14%, and by up to 54% for individuals with a history of skin cancer.
The research involved 33,822 U.S. veterans, with 12,287 receiving 500mg of nicotinamide twice daily.
Nicotinamide aids DNA repair and mitigates UV damage, suggesting its potential as a preventive treatment.
Optimal intervention timing occurs after the first skin cancer diagnosis.
Further research is needed to explore long-term effects and treatment duration.

1 of 1

Story summary

A Vanderbilt University Medical Center study indicates that nicotinamide, a vitamin B3 derivative, may lower skin cancer risk by 14%, and by up to 54% for individuals with a history of skin cancer.
The research involved 33,822 U.S. veterans, with 12,287 receiving 500mg of nicotinamide twice daily.
Nicotinamide aids DNA repair and mitigates UV damage, suggesting its potential as a preventive treatment.
Optimal intervention timing occurs after the first skin cancer diagnosis.
Further research is needed to explore long-term effects and treatment duration.